Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: TO THE BOD

To eliminate those annual rights could result in large scale alienation.

Larger scale than there currently is? And more importantly...do you think they are concerned at all if they are more aliented from shareholders?

Share
New Message
Please login to post a reply